developer novak's launches a trial of its vaccine in south africa just as the country sees a surge in new cases also coming up we take you to see a way to where the coronavirus crisis has created a tick driven business and african leaders gather and gonna open the headquarters of a new free trade zone but they're still working out the details of lucrative. chris coburn berlin welcome to the program u.s. drugmaker novak's is set to begin a mid stage clinical trial of a coronavirus vaccine and south africa study will be conducted around $2600.00 the company says south africa was chosen because it was currently experiencing a winter surge in covert $1000.00 cases and would therefore provide early indications of seasonal efficacy in july the u.s. government awarded novak's $1600000000.00 to help produce a vaccine. as south africa strict code 19 locked down batters africa's most developed economy and the country's informal sector is driven to find new ways to survive it's a way to want to south africa's biggest informal settlements a digital boom is underway. lunchtime in the southwest so